Characteristics of animal models for COVID-19
- PMID: 36301011
- PMCID: PMC9610135
- DOI: 10.1002/ame2.12278
Characteristics of animal models for COVID-19
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), the most consequential pandemic of this century, threatening human health and public safety. SARS-CoV-2 has been continuously evolving through mutation of its genome and variants of concern have emerged. The World Health Organization R&D Blueprint plan convened a range of expert groups to develop animal models for COVID-19, a core requirement for the prevention and control of SARS-CoV-2 pandemic. The animal model construction techniques developed during the SARS-CoV and MERS-CoV pandemics were rapidly deployed and applied in the establishment of COVID-19 animal models. To date, a large number of animal models for COVID-19, including mice, hamsters, minks and nonhuman primates, have been established. Infectious diseases produce unique manifestations according to the characteristics of the pathogen and modes of infection. Here we classified animal model resources around the infection route of SARS-CoV-2, and summarized the characteristics of the animal models constructed via transnasal, localized, and simulated transmission routes of infection.
Keywords: SARS-CoV-2; animal model; characteristics; establishment.
© 2022 The Authors. Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.
Conflict of interest statement
The authors declared no conflict of interest. Chuan Qin is an Editorial Board member of AMEM and a co‐author of this article. To minimize bias, she was excluded from all editorial decision‐making related to the acceptance of this article for publication.
Figures
Similar articles
-
Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.Int Rev Immunol. 2024;43(1):13-32. doi: 10.1080/08830185.2022.2089666. Epub 2022 Jun 25. Int Rev Immunol. 2024. PMID: 35757923 Review.
-
Review of selected animal models for respiratory coronavirus infection and its application in drug research.J Med Virol. 2022 Jul;94(7):3032-3042. doi: 10.1002/jmv.27718. Epub 2022 Mar 24. J Med Virol. 2022. PMID: 35285034 Free PMC article. Review.
-
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.mBio. 2020 Sep 25;11(5):e02168-20. doi: 10.1128/mBio.02168-20. mBio. 2020. PMID: 32978313 Free PMC article.
-
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.EBioMedicine. 2020 May;55:102743. doi: 10.1016/j.ebiom.2020.102743. Epub 2020 Apr 2. EBioMedicine. 2020. PMID: 32249203 Free PMC article.
-
Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.Przegl Epidemiol. 2020;74(2):276-289. doi: 10.32394/pe.74.21. Przegl Epidemiol. 2020. PMID: 33112124
Cited by
-
A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.J Virol. 2024 Jul 23;98(7):e0050424. doi: 10.1128/jvi.00504-24. Epub 2024 Jun 20. J Virol. 2024. PMID: 38899934 Free PMC article.
-
Use of a Preclinical Natural Transmission Model to Study Antiviral Effects of a Carbohydrate-Binding Module Therapy against SARS-CoV-2 in Hamsters.Viruses. 2023 Mar 11;15(3):725. doi: 10.3390/v15030725. Viruses. 2023. PMID: 36992434 Free PMC article.
-
Comparison of the pathogenicity and neutrophil and monocyte response between SARS-CoV-2 prototype and Omicron BA.1 in a lethal mouse model.Animal Model Exp Med. 2025 Apr;8(4):707-717. doi: 10.1002/ame2.12419. Epub 2024 May 17. Animal Model Exp Med. 2025. PMID: 38760905 Free PMC article.
-
Editorial: Cellular and molecular mechanisms of neurotropic viral infection.Front Cell Neurosci. 2024 Jan 16;18:1365755. doi: 10.3389/fncel.2024.1365755. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38293293 Free PMC article. No abstract available.
-
The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease.Viruses. 2024 Oct 30;16(11):1701. doi: 10.3390/v16111701. Viruses. 2024. PMID: 39599816 Free PMC article. Review.
References
-
- Pe F, Mc A, Sd C, et al. Association Between Comorbidities and Death From COVID‐19 in Different Age Groups. Cold Spring Harbor Laboratory Press; 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous